The Future of Virtual Healthcare With Teladoc

Recently, Teladoc released its 2018 revenue of $418 million, which was up nearly 80% from the year prior. The Company continues to expand year after year due in large part by the ambitious agenda of its CEO Jason Gorevic.

Gorevic joined Teladoc as CEO in 2009. Previously he was the Chief Marketing and Product Officer and President of WellPoint and before that was Chief Sales and Marketing Officer of BlueCross BlueShield. Gorevic, a graduate of the University of Pennsylvania, started his career with Oxford Health Plans.

He has grown Teladoc at an astounding rate. Since 2015, revenue has gone from $77 million to $123 million to $233 million and to $418 million in each of the subsequent years while steadily holding net income at close to breakeven. A spectacular feat for any CEO in any industry.

Founded in 2002, Teladoc is the nation’s first and largest provider of telehealth services. With more than 3 million members nationwide and an average response time of 22 minutes, Teladoc enhances access to affordable, high-quality medical care for adults and children via videoconferencing or telephone consultations 24/7.

The U.S.-based, board-certified physicians meet or exceed National Committee for Quality Assurance (NCQA) standards and delivers a 97 percent patient satisfaction rate. Teladoc partners with payers, corporations, organizations and patients that seek accessible and affordable high-quality medical care. Additionally, through its TeladocConnect service, physicians are able to offer the convenience of Teladoc and provide their patients with a high level of care around the clock.

With more than 2,000 employees, the Company delivers care in 125 countries and in more than 20 languages, partnering with employers, hospitals and health systems, and insurers to transform care delivery.

Gorevic is a two-time winner of the WellPoint Pinnacle Award for outstanding leadership and at the age of 31, was named one of the 2003 Crain's New York Business "40 Under 40" top executives.